Neuronetics, Inc. Basic Shares Outstanding (Weighted Average)
Neuronetics, Inc. (STIM) reported Basic Shares Outstanding (Weighted Average) of 73.13 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Neuronetics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 73.13M shares, a 10.50% increase year-over-year.
- Neuronetics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 69.59M shares, a 13.22% increase year-over-year.
- Neuronetics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 68.79M shares, a 85.19% increase year-over-year.
- Neuronetics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 67.31M shares, a 122.38% increase year-over-year.
- Neuronetics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 65.95M shares, a 107.82% increase from fiscal 2024.
- Neuronetics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 31.73M shares, a 10.73% increase from fiscal 2023.
- Neuronetics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 28.66M shares, a 6.54% increase from fiscal 2022.
- Neuronetics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 26.90M shares, a 5.58% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 73.13M shares 10-Q · filed 2026-08-11 | 71.37M shares 10-Q · filed 2026-08-11 | 70.50M shares derived: average of 3 quarters · filed 2026-08-11 | 69.70M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | 69.59M shares 10-Q · filed 2026-05-05 | 69.19M shares derived: average of 2 quarters · filed 2026-05-05 | 68.56M shares derived: average of 3 quarters · filed 2026-05-05 | 67.97M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | 68.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 68.05M shares derived: average of 2 quarters · filed 2026-03-17 | 67.42M shares derived: average of 3 quarters · filed 2026-08-11 | 65.95M shares 10-K · filed 2026-03-17 | ||
| 2025-09-30 | 67.31M shares 10-Q · filed 2025-11-04 | 66.74M shares derived: average of 2 quarters · filed 2026-08-11 | 65.01M shares 10-Q · filed 2025-11-04 | 58.02M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | 66.18M shares 10-Q · filed 2026-08-11 | 63.84M shares 10-Q · filed 2026-08-11 | 54.93M shares derived: average of 3 quarters · filed 2026-08-11 | 48.76M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | 61.47M shares 10-Q · filed 2026-05-05 | 49.30M shares derived: average of 2 quarters · filed 2026-05-05 | 42.96M shares derived: average of 3 quarters · filed 2026-05-05 | 39.73M shares derived: average of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | 37.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 33.70M shares derived: average of 2 quarters · filed 2026-03-17 | 32.49M shares derived: average of 3 quarters · filed 2026-03-17 | 31.73M shares 10-K · filed 2026-03-17 | ||
| 2024-09-30 | 30.27M shares 10-Q · filed 2025-11-04 | 30.16M shares derived: average of 2 quarters · filed 2025-11-04 | 29.93M shares 10-Q · filed 2025-11-04 | 22.75M shares derived: average of 4 quarters · filed 2026-03-17 | ||
| 2024-06-30 | 30.05M shares 10-Q · filed 2025-08-05 | 29.76M shares 10-Q · filed 2025-08-05 | 20.24M shares derived: average of 3 quarters · filed 2026-03-17 | 25.74M shares derived: average of 4 quarters · filed 2026-03-17 | ||
| 2024-03-31 | 29.47M shares 10-Q · filed 2025-05-06 | 15.34M shares derived: average of 2 quarters · filed 2026-03-17 | 24.30M shares derived: average of 3 quarters · filed 2026-03-17 | 25.37M shares derived: average of 4 quarters · filed 2026-03-17 | ||
| 2023-12-31 | 1.20M shares derived: 10-K 12 month − 8-K/A 9 month · filed 2026-03-17 | 21.72M shares derived: average of 2 quarters · filed 2026-03-17 | 24.01M shares derived: average of 3 quarters · filed 2026-03-17 | 28.66M shares 10-K · filed 2026-03-17 | ||
| 2023-09-30 | 42.23M shares 8-K/A · filed 2025-02-06 | 28.88M shares 10-Q · filed 2023-11-07 | 35.41M shares derived: average of 2 quarters · filed 2025-02-06 | 37.81M shares 8-K/A · filed 2025-02-06 | 28.50M shares 10-Q · filed 2023-11-07 | 31.52M shares derived: average of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | 28.59M shares 10-Q · filed 2024-08-12 | 28.32M shares 10-Q · filed 2024-08-12 | 27.94M shares derived: average of 3 quarters · filed 2025-03-27 | 27.70M shares derived: average of 4 quarters · filed 2025-03-27 | ||
| 2023-03-31 | 28.03M shares 10-Q · filed 2024-05-07 | 27.62M shares derived: average of 2 quarters · filed 2025-03-27 | 27.40M shares derived: average of 3 quarters · filed 2025-03-27 | 27.25M shares derived: average of 4 quarters · filed 2025-03-27 | ||
| 2022-12-31 | 27.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 27.09M shares derived: average of 2 quarters · filed 2025-03-27 | 26.99M shares derived: average of 3 quarters · filed 2025-03-27 | 26.90M shares 10-K · filed 2025-03-27 | ||
| 2022-09-30 | 26.96M shares 10-Q · filed 2023-11-07 | 26.88M shares derived: average of 2 quarters · filed 2023-11-07 | 26.80M shares 10-Q · filed 2023-11-07 | 26.68M shares derived: average of 4 quarters · filed 2024-03-08 | ||
| 2022-06-30 | 26.79M shares 10-Q · filed 2023-08-08 | 26.69M shares 10-Q · filed 2023-08-08 | 26.59M shares derived: average of 3 quarters · filed 2024-03-08 | 26.52M shares derived: average of 4 quarters · filed 2024-03-08 | ||
| 2022-03-31 | 26.60M shares 10-Q · filed 2023-05-15 | 26.49M shares derived: average of 2 quarters · filed 2024-03-08 | 26.43M shares derived: average of 3 quarters · filed 2024-03-08 | 26.30M shares derived: average of 4 quarters · filed 2024-03-08 | ||
| 2021-12-31 | 26.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | 26.34M shares derived: average of 2 quarters · filed 2024-03-08 | 26.19M shares derived: average of 3 quarters · filed 2024-03-08 | 25.48M shares 10-K · filed 2024-03-08 | ||
| 2021-09-30 | 26.30M shares 10-Q · filed 2022-11-08 | 26.10M shares derived: average of 2 quarters · filed 2022-11-08 | 25.18M shares 10-Q · filed 2022-11-08 | 24.09M shares derived: average of 4 quarters · filed 2023-03-07 | ||
| 2021-06-30 | 25.90M shares 10-Q · filed 2022-08-02 | 24.61M shares 10-Q · filed 2022-08-02 | 23.36M shares derived: average of 3 quarters · filed 2023-03-07 | 22.24M shares derived: average of 4 quarters · filed 2023-03-07 | ||
| 2021-03-31 | 25.15M shares 10-Q · filed 2022-05-12 | 22.09M shares derived: average of 2 quarters · filed 2023-03-07 | 21.02M shares derived: average of 3 quarters · filed 2023-03-07 | 20.45M shares derived: average of 4 quarters · filed 2023-03-07 | ||
| 2020-12-31 | 19.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 18.96M shares derived: average of 2 quarters · filed 2023-03-07 | 18.89M shares derived: average of 3 quarters · filed 2023-03-07 | 18.84M shares 10-K · filed 2023-03-07 | ||
| 2020-09-30 | 18.89M shares 10-Q · filed 2021-11-09 | 18.82M shares derived: average of 2 quarters · filed 2021-11-09 | 18.77M shares 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | 18.75M shares 10-Q · filed 2021-08-03 | 18.71M shares 10-Q · filed 2021-08-03 | ||||
| 2019-12-31 | 18.38M shares 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |